NanoString Technologies this week announced the availability of nCounter Elements, general purpose reagents developed for translational research and clinical laboratories.
The reagents rely on the company's digital molecular barcoding chemistry. Users can use the reagents to assemble their own customized assays using standard sets of barcodes provided by NanoString and probes that they can purchase independently from an oligonucleotide manufacturer, the company said.
The reagents have also been registered with the US Food and Drug Administrations as general purpose reagents, and are available for use in developing laboratory-developed tests.
NanoString said that customers in its early access program will receive the first shipments of nCounter Elements GPRs in the third quarter. They will be able to provide feedback prior to full commercialization.